A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohume…

Facioscapulohumeral Muscular DystrophyFSHDFSHD - Facioscapulohumeral Muscular Dystrophy+14 more

~Estimated

~$10 – $8,750

Avidity Biosciences, Inc.NCT07038200

BetterLife FSHD: A Patient-driven Health and Research Platform

BetterLife FSHD is a registry platform built to support people living with FSHD. It connects patients with personalized resources, tools, and research opportun…

FSHFSH Muscular DystrophyFSHD - Facioscapulohumeral Muscular Dystrophy+8 more

~Estimated

~$10 – $1,125

FSHD SocietyNCT07409142